Kiromic Biopharma Inc. WKN: A3D7BN ISIN: US4976342042 Kürzel: KRBP Forum: Aktien User: Solix
0,91 USD
-9,00 %-0,09
27. Nov, 20:09:33 Uhr,
Nasdaq OTC
Kommentare 26
Molly69,
03.05.2023 12:38 Uhr
0
Was ist los hier? Wie lange dürfen wir in Deutschland nicht handeln? Warum ist sie ausgesetzt?
Summer.76,
03.05.2023 20:48 Uhr
0
What's Going On With Kiromic BioPharma Stock Wednesday
https://www.benzinga.com/general/biotech/23/05/32190317/whats-going-on-with-kiromic-biopharma-stock-wednesday
Kiromic BioPharma Inc (NASDAQ:KRBP) shares
are gaining Wednesday morning. However
there is no specific news today. During the
session, the share price reached $9.22.
Monday morning, the FDA authorized the
company's Investigational New Drug (IND)
application to initiate a Phase 1 trial to
evaluate Deltacel (KB-GDT-01) for patients with
non-small cell lung cancer (NSCLC).
The company expects to start the trial in Q2 of
2023.
Deltacel is the company's allogeneic, non-
engineered, off-the-shelf Gamma Delta T-cell
therapy.
The company submitted the IND application in
early April.
Kiromic BioPharma stock is gaining on heavy
volume, with a session volume of 3.6 million
shares traded, compared to the trailing 100-
day volume of 164.038K shares.
Summer.76,
22.05.2023 19:36 Uhr
0
Kiromic BioPharma Submits SEC Filing Of Biotech AI Play; A Slide Deck With Artificial Intelligence - Diamond Artificial Intelligence Platform To Discover & Develop Cell Therapies In Lung Cancer In New Presentation
https://www.benzinga.com/news/23/05/32513092/kiromic-biopharma-submits-sec-filing-of-biotech-ai-play-just-posted-a-slide-deck-with-artificial-int
Summer.76,
14.09.2023 7:19 Uhr
0
KRBP Suspended from Trading on Nasdaq
Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14
https://www.businesswire.com/news/home/20230913097444/en/Kiromic-BioPharma-Common-Stock-to-Begin-Trading-on-the-OTC-Pink-Sheets-on-September-14
Summer.76,
01.05.2023 16:08 Uhr
0
https://ir.kiromic.com/news-releases/news-release-details/kiromic-biopharma-announces-fda-authorization-ind-initiate-phase
Summer.76,
03.04.2023 14:22 Uhr
0
https://ir.kiromic.com/news-releases/news-release-details/kiromic-biopharma-submits-investigational-new-drug-application
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +137,90 % | |
2 | Spineway Act Hauptdiskussion | +92,77 % | |
3 | Europlasma Hauptdiskussion | +389,90 % | |
4 | MicroStrategy | +8,36 % | |
5 | BTC/USD Hauptdiskussion | +6,53 % | |
6 | COVESTRO AG O.N. Hauptdiskussion | -0,12 % | |
7 | für alle, die es ehrlich meinen beim Traden. | ||
8 | NVIDIA Hauptdiskussion | -2,33 % | |
9 | Zukunft Ocugen | +1,35 % | |
10 | Palantir ohne Schnickschnack | -0,65 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | +135,48 % | |
2 | Spineway Act Hauptdiskussion | +74,70 % | |
3 | Europlasma Hauptdiskussion | +321,50 % | |
4 | MicroStrategy | +8,38 % | |
5 | COVESTRO AG O.N. Hauptdiskussion | -0,12 % | |
6 | NVIDIA Hauptdiskussion | -2,26 % | |
7 | Zukunft Ocugen | +1,35 % | |
8 | Palantir ohne Schnickschnack | -0,67 % | |
9 | GAMESTOP Hauptdiskussion | +1,41 % | |
10 | MICROSTRATEGY Hauptdiskussion | +8,38 % | Alle Diskussionen |